333 related articles for article (PubMed ID: 33372284)
1. Erythroferrone structure, function, and physiology: Iron homeostasis and beyond.
Srole DN; Ganz T
J Cell Physiol; 2021 Jul; 236(7):4888-4901. PubMed ID: 33372284
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietic regulators of iron metabolism.
Ganz T
Free Radic Biol Med; 2019 Mar; 133():69-74. PubMed ID: 29981834
[TBL] [Abstract][Full Text] [Related]
3. Characterization of erythroferrone structural domains relevant to its iron-regulatory function.
Srole DN; Jung G; Waring AJ; Nemeth E; Ganz T
J Biol Chem; 2023 Dec; 299(12):105374. PubMed ID: 37866631
[TBL] [Abstract][Full Text] [Related]
4. Erythroid overproduction of erythroferrone causes iron overload and developmental abnormalities in mice.
Coffey R; Jung G; Olivera JD; Karin G; Pereira RC; Nemeth E; Ganz T
Blood; 2022 Jan; 139(3):439-451. PubMed ID: 34614145
[TBL] [Abstract][Full Text] [Related]
5. Erythroferrone and hepcidin as mediators between erythropoiesis and iron metabolism during allogeneic hematopoietic stem cell transplant.
Pirotte M; Fillet M; Seidel L; Jaspers A; Baron F; Beguin Y
Am J Hematol; 2021 Oct; 96(10):1275-1286. PubMed ID: 34310730
[TBL] [Abstract][Full Text] [Related]
6. Erythroferrone exacerbates iron overload and ineffective extramedullary erythropoiesis in a mouse model of β-thalassemia.
Olivera J; Zhang V; Nemeth E; Ganz T
Blood Adv; 2023 Jul; 7(14):3339-3349. PubMed ID: 36995275
[TBL] [Abstract][Full Text] [Related]
7. Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of β-thalassemia.
Kautz L; Jung G; Du X; Gabayan V; Chapman J; Nasoff M; Nemeth E; Ganz T
Blood; 2015 Oct; 126(17):2031-7. PubMed ID: 26276665
[TBL] [Abstract][Full Text] [Related]
8. A variant erythroferrone disrupts iron homeostasis in
Bondu S; Alary AS; Lefèvre C; Houy A; Jung G; Lefebvre T; Rombaut D; Boussaid I; Bousta A; Guillonneau F; Perrier P; Alsafadi S; Wassef M; Margueron R; Rousseau A; Droin N; Cagnard N; Kaltenbach S; Winter S; Kubasch AS; Bouscary D; Santini V; Toma A; Hunault M; Stamatoullas A; Gyan E; Cluzeau T; Platzbecker U; Adès L; Puy H; Stern MH; Karim Z; Mayeux P; Nemeth E; Park S; Ganz T; Kautz L; Kosmider O; Fontenay M
Sci Transl Med; 2019 Jul; 11(500):. PubMed ID: 31292266
[TBL] [Abstract][Full Text] [Related]
9. The hepcidin regulator erythroferrone is a new member of the erythropoiesis-iron-bone circuitry.
Castro-Mollo M; Gera S; Ruiz-Martinez M; Feola M; Gumerova A; Planoutene M; Clementelli C; Sangkhae V; Casu C; Kim SM; Ostland V; Han H; Nemeth E; Fleming R; Rivella S; Lizneva D; Yuen T; Zaidi M; Ginzburg Y
Elife; 2021 May; 10():. PubMed ID: 34002695
[TBL] [Abstract][Full Text] [Related]
10. Associations among Erythroferrone and Biomarkers of Erythropoiesis and Iron Metabolism, and Treatment with Long-Term Erythropoiesis-Stimulating Agents in Patients on Hemodialysis.
Honda H; Kobayashi Y; Onuma S; Shibagaki K; Yuza T; Hirao K; Yamamoto T; Tomosugi N; Shibata T
PLoS One; 2016; 11(3):e0151601. PubMed ID: 26978524
[TBL] [Abstract][Full Text] [Related]
11. Identification of erythroferrone as an erythroid regulator of iron metabolism.
Kautz L; Jung G; Valore EV; Rivella S; Nemeth E; Ganz T
Nat Genet; 2014 Jul; 46(7):678-84. PubMed ID: 24880340
[TBL] [Abstract][Full Text] [Related]
12. New insights into iron regulation and erythropoiesis.
Kim A; Nemeth E
Curr Opin Hematol; 2015 May; 22(3):199-205. PubMed ID: 25710710
[TBL] [Abstract][Full Text] [Related]
13. Erythroferrone inhibits the induction of hepcidin by BMP6.
Arezes J; Foy N; McHugh K; Sawant A; Quinkert D; Terraube V; Brinth A; Tam M; LaVallie ER; Taylor S; Armitage AE; Pasricha SR; Cunningham O; Lambert M; Draper SJ; Jasuja R; Drakesmith H
Blood; 2018 Oct; 132(14):1473-1477. PubMed ID: 30097509
[TBL] [Abstract][Full Text] [Related]
14. Immunoassay for human serum erythroferrone.
Ganz T; Jung G; Naeim A; Ginzburg Y; Pakbaz Z; Walter PB; Kautz L; Nemeth E
Blood; 2017 Sep; 130(10):1243-1246. PubMed ID: 28739636
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Hepcidin by Erythropoiesis: The Story So Far.
Pasricha SR; McHugh K; Drakesmith H
Annu Rev Nutr; 2016 Jul; 36():417-34. PubMed ID: 27146013
[TBL] [Abstract][Full Text] [Related]
16. The effect of erythroferrone suppression by transfusion on the erythropoietin-erythroferrone-hepcidin axis in transfusion-dependent thalassaemia: A pre-post cohort study.
Zaman BA; Rasool SO; Abdo JM
Br J Haematol; 2023 May; 201(3):547-551. PubMed ID: 36535905
[TBL] [Abstract][Full Text] [Related]
17. Limiting hepatic Bmp-Smad signaling by matriptase-2 is required for erythropoietin-mediated hepcidin suppression in mice.
Nai A; Rubio A; Campanella A; Gourbeyre O; Artuso I; Bordini J; Gineste A; Latour C; Besson-Fournier C; Lin HY; Coppin H; Roth MP; Camaschella C; Silvestri L; Meynard D
Blood; 2016 May; 127(19):2327-36. PubMed ID: 26755707
[TBL] [Abstract][Full Text] [Related]
18. EPO-R+ myelodysplastic cells with ring sideroblasts produce high erythroferrone levels to reduce hepcidin expression in hepatic cells.
Miura S; Kobune M; Horiguchi H; Kikuchi S; Iyama S; Murase K; Goto A; Ikeda H; Takada K; Miyanishi K; Kato J
Blood Cells Mol Dis; 2019 Sep; 78():1-8. PubMed ID: 31082798
[TBL] [Abstract][Full Text] [Related]
19. The association between growth differentiation factor-15, erythroferrone, and iron status in thalassemic patients.
Youssry I; Samy RM; AbdelMohsen M; Salama NM
Pediatr Res; 2024 Mar; 95(4):1095-1100. PubMed ID: 37464096
[TBL] [Abstract][Full Text] [Related]
20. Antibodies against the erythroferrone N-terminal domain prevent hepcidin suppression and ameliorate murine thalassemia.
Arezes J; Foy N; McHugh K; Quinkert D; Benard S; Sawant A; Frost JN; Armitage AE; Pasricha SR; Lim PJ; Tam MS; Lavallie E; Pittman DD; Cunningham O; Lambert M; Murphy JE; Draper SJ; Jasuja R; Drakesmith H
Blood; 2020 Feb; 135(8):547-557. PubMed ID: 31899794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
